Embecta Corp (EMBC)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $366.02M
Last updated: Nov 17, 2026 at 11:05 AM ET
Embecta Corp (EMBC) Earnings: Report Dates and Results
Embecta (EMBC) is expected to report earnings on Nov 23, 2026. In the quarter ended Jun 30, 2026, Embecta reported EPS of $0.56, above the $0.26 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
EMBC has an expected report date of Nov 23, 2026. Analysts' consensus for the quarter ended Sep 30, 2026 is 40.0% below the $0.50 reported for the quarter ended Sep 30, 2025.
EMBC Earnings Call
The latest EMBC earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptEarnings History
Of the 17 quarters below that had an estimate, EMBC beat 16 and missed 1. Revenue for the quarter ended Jun 30, 2026 was $271.70M, down 8.1% from $295.50M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | $0.56 | $0.26 | $0.25 - $0.29 | +115.38% | Beat | -50.0% | 4 | 0 up, 4 down | Aug 7, 2026 | $271.70M |
| Mar 31, 2026 | $0.27 | $0.42 | $0.41 - $0.42 | -35.71% | Miss | -61.4% | 4 | 0 up, 2 down | May 5, 2026 | $221.80M |
| Dec 31, 2025 | $0.71 | $0.67 | $0.66 - $0.68 | +5.97% | Beat | +9.2% | 4 | 0 up, 2 down | Feb 5, 2026 | $261.20M |
| Sep 30, 2025 | $0.50 | $0.46 | $0.44 - $0.47 | +8.70% | Beat | +11.1% | 4 | 0 up, 4 down | Nov 25, 2025 | $264.00M |
| Jun 30, 2025 | $1.12 | $0.78 | $0.75 - $0.82 | +43.59% | Beat | +51.4% | 4 | 1 up, 4 down | Aug 8, 2025 | $295.50M |
| Mar 31, 2025 | $0.70 | $0.59 | $0.48 - $0.73 | +18.64% | Beat | +4.5% | 4 | 0 up, 2 down | May 9, 2025 | $259.00M |
| Dec 31, 2024 | $0.65 | $0.44 | $0.43 - $0.46 | +47.73% | Beat | +6.6% | 4 | 0 up, 3 down | Feb 6, 2025 | $261.90M |
| Sep 30, 2024 | $0.45 | $0.36 | $0.30 - $0.59 | +25.00% | Beat | -23.7% | 5 | 1 up, 3 down | Nov 26, 2024 | $286.10M |
| Jun 30, 2024 | $0.74 | $0.46 | $0.41 - $0.51 | +60.87% | Beat | +7.2% | 5 | 0 up, 0 down | Aug 9, 2024 | $272.50M |
| Mar 31, 2024 | $0.67 | $0.40 | $0.37 - $0.47 | +67.50% | Beat | -10.7% | 4 | 0 up, 0 down | May 9, 2024 | $287.20M |
| Dec 31, 2023 | $0.61 | $0.46 | $0.43 - $0.47 | +32.61% | Beat | -36.5% | 4 | 0 up, 0 down | Feb 9, 2024 | $277.30M |
| Sep 30, 2023 | $0.59 | $0.40 | $0.37 - $0.47 | +47.50% | Beat | -50.0% | 4 | 0 up, 0 down | Nov 21, 2023 | $281.90M |
| Jun 30, 2023 | $0.69 | $0.46 | $0.45 - $0.47 | +50.00% | Beat | -43.0% | 3 | 0 up, 0 down | Aug 8, 2023 | $286.10M |
| Mar 31, 2023 | $0.75 | $0.48 | $0.45 - $0.53 | +56.25% | Beat | -45.7% | 3 | 0 up, 0 down | May 12, 2023 | $277.10M |
| Dec 31, 2022 | $0.96 | $0.52 | $0.50 - $0.53 | +84.62% | Beat | -86.6% | 2 | 0 up, 0 down | Feb 14, 2023 | $275.70M |
| Sep 30, 2022 | $1.18 | $0.67 | $0.61 - $0.72 | +76.12% | Beat | N/A | 2 | 0 up, 1 down | Dec 20, 2022 | $274.60M |
| Jun 30, 2022 | $1.21 | $0.87 | $0.87 - $0.87 | +39.08% | Beat | N/A | 1 | 0 up, 0 down | Aug 15, 2022 | $291.10M |
| Mar 31, 2022 | $1.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2022 | $274.50M |
| Dec 31, 2021 | $7.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 16, 2022 | $289.30M |
Annual EPS
EPS for the fiscal year ended Sep 30, 2026 was $1.54, down 48.1% from the year before. It was $10.94 for the year ended Sep 30, 2022, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | $1.54 | -48.1% |
| Sep 30, 2025 | $2.97 | +20.2% |
| Sep 30, 2024 | $2.47 | -17.4% |
| Sep 30, 2023 | $2.99 | -72.7% |
| Sep 30, 2022 | $10.94 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 6,700 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q2 | Jun 30, 2026 | 6,675 | 7 | |
| 2026Q1 | Mar 31, 2026 | 5,069 | 8 | |
| 2025Q4 | Dec 31, 2025 | 6,919 | 8 | |
| 2025Q3 | Sep 30, 2025 | 5,244 | 8 | |
| 2025Q2 | Jun 30, 2025 | 6,657 | 8 | |
| 2025Q1 | Mar 31, 2025 | 6,154 | 7 | |
| 2024Q4 | Dec 31, 2024 | 7,554 | 7 | |
| 2024Q3 | Sep 30, 2024 | 6,100 | 8 |
2026Q2 Earnings Call
Opening remarks
Pravesh Khandelwal Vice President, Investor Relations Good morning, everyone, and welcome to embecta's fiscal second quarter 2026 earnings conference call. The press release and slides to accompany today's call, along with webcast replay details are available on the Investor Relations section of our website at www.embecta.com. With me today are Dev Kurdikar, embecta's Chairman and Chief Executive Officer; and Jake Elguicze, our Chief Financial Officer. Before we begin, I would like to remind you that some of the matters discussed in the conference call will contain forward-looking statements regarding future events as outlined in our slides, including those referenced on Slide 2 of today's conference call presentation. Such statements are, in fact, forward-looking in nature and are subject to risks and uncertainties, and actual events or results may differ materially. The factors that could cause actual results or events to differ materially include, but are not limited to, factors referenced in our press release today as well as our filings with the SEC, which can be accessed on our website. We do not intend to update or revise any forward-looking statements, including any charts, financial projections or other data referenced in this presentation, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, we will discuss certain non-GAAP financial measures on this call, which should be considered a supplement to and not a substitute for financial measures prepared in accordance with GAAP. A reconciliation of these non-GAAP measures to the comparable GAAP measures is included in our press release and conference call presentation, which are also included in the Investors section of our website at embecta.com. Our agenda for today's call is as follows. Dev will begin with an assessment of the company's performance during the second quarter and associated financial guidance implications. We will also share the progress we have made on our strategic objectives and will discuss the expected imminent closing of the Owen Mumford acquisition. Jake will then take you through our second quarter financial results in more detail as well as our updated fiscal year 2026 guidance. Dev will then conclude with our updated approach to capital allocation, and we will open the call for questions. With that, I will now turn the call over to Dev.
Devdatt Kurdikar Chairman and Chief Executive Officer Good morning, everyone, and thank you for joining us today. I want to start the call by addressing our second quarter performance and full year guidance revision. This was a difficult quarter for embecta. Our results were below expectations with consolidated revenues down 14.4% year-over-year on an as-reported basis or 17.4% on an adjusted constant currency basis.
Frequently Asked Questions About EMBC
When is Embecta's next earnings date?
Embecta's next earnings report is expected for Nov 23, 2026.
Did EMBC beat earnings estimates last quarter?
Yes. Embecta reported EPS of $0.56 for the quarter ended Jun 30, 2026, above the $0.26 estimate, a 115.38% surprise.
What EPS do analysts expect from EMBC next quarter?
The consensus EPS estimate for Embecta for the quarter ended Sep 30, 2026 is $0.30 from 6 analysts, with estimates from $0.27 to $0.33.
How often does EMBC beat earnings estimates?
Embecta beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +28.66%.
EMBC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors